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ABSTRACT 
Background Inefficient cellular delivery and poor intracellular accumulation are major 
drawbacks towards achieving favorable therapeutic responses from many therapeutic drugs and 
biomolecules. To tackle this issue, nanoparticle-mediated delivery vectors have been aptly 
explored as a promising delivery strategy capable of enhancing the cellular localization of 
biomolecules and improve their therapeutic efficacies. However, the dynamics of intracellular 
biomolecule release and accumulation from such nanoparticle systems has currently remained 
scarcely studied. Objectives The objective of this study was to utilize a chitosan-based 
nanoparticle system as the delivery carrier for glutamic acid, a model for encapsulated 
biomolecules to visualize the in vitro release and accumulation of the encapsulated glutamic acid 
from chitosan nanoparticle (CNP) systems. Methods CNP was synthesized via ionic gelation 
routes utilizing tripolyphosphate (TPP) as a cross-linker. In order to track glutamic acid release, 
the glutamic acid was fluorescently-labeled with fluorescein isothiocyanate prior encapsulation 
into CNP. Results Light Scattering data concluded the successful formation of small-sized and 
mono-dispersed CNP at a specific volume ratio of chitosan to TPP. Encapsulation of glutamic 
acid as a model cargo into CNP led to an increase in particle size to >100 nm. The synthesized 
CNP exhibited spherical shape under Electron Microscopy. The formation of CNP was reflected 
by the reduction in free amine groups of chitosan following ionic crosslinking reactions. The 
encapsulation of glutamic acid was further confirmed by Fourier Transform Infrared (FTIR) 
analysis. Cell viability assay showed 70% cell viability at the maximum concentration of 0.5 
mg/mL CS and 0.7 mg/mL TPP used, indicating the low inherent toxicity property of this 
system. In vitro release study using fluorescently-tagged glutamic acids demonstrated the release 
and accumulation of the encapsulated glutamic acids at 6 hours post treatment. A significant 
accumulation was observed at 24 hours and 48 hours later. Flow cytometry data demonstrated a 
gradual increase in intracellular fluorescence signal from 30 minutes to 48 hours post treatment 
with fluorescently-labeled glutamic acids encapsulated CNP. Conclusion These results therefore 
suggested the potential of CNP system towards enhancing the intracellular delivery and release 
of the encapsulated glutamic acids. This CNP system thus may serves as a potential candidate 
vector capable to improve the therapeutic efficacy for drugs and biomolecules in medical as well 
as pharmaceutical applications through the enhanced intracellular release and accumulation of 
the encapsulated cargo.  
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